Skip to main content

Table 1 Patient characteristics

From: Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

  Gefitinib Erlotinib
  No % No %
TOTAL 115   45  
Gender     
   Female 55 48 30 67
   Male 60 52 15 33
Age     
   Avg. age 66.53   66.76  
   Range 45-86   35-82  
Smoking history     
   Smokers 109 95 39 87
   Non-smokers 5 1 4 9
   Unknown 1 1 2 4
   Avg. pack-years 43.6   42.2  
Histology     
   Adenocarcinoma 54 47 15 33
   Squamous 27 23 9 20
   Bronchioalveolar 8 6 2 4
   Large cell 6 5 0 0
   Mixed 2 2 0 0
   NSC not further specified 17 15 20 44
Avg. ECOG 1.37   1.37  
Avg. previous lines of chemo 1.26   1.13